Mesoblast LtdMESO
Price (close)
$15.48
Market cap
$2.0B
P/E
—
Revenue (FY)
$17.2M
Net income
-$102.1M
Dividend yield
—
1-year total return
-5.1%
Net margin
-593.9%
Revenue growth
191.4%
Debt / equity
0.11x
What Mesoblast Ltd does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $32.2M | $7.4M | $10.2M | $7.5M | $5.9M | $17.2M |
| Net income | -$77.9M | -$98.8M | -$91.3M | -$81.9M | -$88.0M | -$102.1M |
| Free cash flow | — | — | — | -$63.5M | -$48.7M | -$50.6M |
More on MESO.
- Mesoblast Ltd summary
- Mesoblast Ltd financial statements
- Mesoblast Ltd key metrics
- Mesoblast Ltd health scores and style box
- Mesoblast Ltd earnings
- Mesoblast Ltd dividends
- Mesoblast Ltd valuation
- Mesoblast Ltd ownership and insiders
- Mesoblast Ltd peers
Figures from Mesoblast Ltd's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.